Latest Strategic Refocus News

Enero Group has appointed Ian Ball as its new CEO, marking a pivotal leadership transition following significant operational achievements and a strategic refocus.

C29 Metals has exited its Kazakhstan operations to focus on advancing its Mayfield Copper & Gold Project in Queensland, securing a three-year exploration license extension and confirming strong geological potential.

New Age Exploration has finalized the sale of its Lochinvar Metallurgical Coal Project, entering a royalty agreement that could yield up to A$15 million, while sharpening its focus on gold and lithium assets in Australia and New Zealand.

Epsilon Healthcare and its subsidiaries have officially exited voluntary administration and Deeds of Company Arrangement, marking a pivotal recovery milestone supported by significant personal commitments from the new board. The company now shifts focus to strategic growth and rebuilding trust.

Collins Foods delivered resilient FY25 results with solid revenue growth and a strategic pivot towards German market expansion, while addressing profitability challenges in the Netherlands.

Dubber Corporation has initiated court proceedings against its former auditors following a $26.6 million misappropriation uncovered in FY24, aiming to restore financial stability by year-end.

Credit Intelligence Ltd has announced a conditional agreement to sell its loss-making subsidiary Credit Intelligence Holding Limited for AUD 1.5 million, pending shareholder approval and regulatory clearances.

Lanthanein Resources has withdrawn from its farm-in agreement on the Lady Grey Lithium Project, signaling a strategic pivot. The company is now focusing on other growth opportunities to boost shareholder value.

Minerals 260 has agreed to sell its Aston Lithium-REE Project to Delta Lithium for $450,000 cash plus a 1.5% royalty, redirecting its efforts toward advancing the 2.3 million ounce Bullabulling Gold Project in Western Australia.

Healius Limited has completed the $822 million cash sale of Lumus Imaging to Affinity Equity Partners, setting the stage for a strategic refocus on pathology and a substantial special dividend payout.

Helix Resources has secured conditional agreements to acquire the White Hills copper-gold project and earn a 40% stake in the Gold Basin oxide gold project in Arizona, complementing its Australian assets and setting the stage for a capital raise and drilling campaign.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.